MORGAN STANLEY - VIR BIOTECHNOLOGY INC ownership

VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 144 filers reported holding VIR BIOTECHNOLOGY INC in Q4 2020. The put-call ratio across all filers is 1.24 and the average weighting 0.2%.

Quarter-by-quarter ownership
MORGAN STANLEY ownership history of VIR BIOTECHNOLOGY INC
ValueSharesWeighting
Q3 2023$13,000,089
-23.2%
1,387,416
+101.2%
0.00%
-50.0%
Q2 2023$16,918,980
+21.4%
689,726
+15.2%
0.00%
+100.0%
Q1 2023$13,935,426
-53.3%
598,858
-49.2%
0.00%
-66.7%
Q4 2022$29,810,825
+35.0%
1,177,828
+2.8%
0.00%0.0%
Q3 2022$22,088,000
-19.8%
1,145,658
+5.9%
0.00%
-25.0%
Q2 2022$27,544,000
+81.0%
1,081,374
+82.8%
0.00%
+100.0%
Q1 2022$15,218,000
-70.5%
591,678
-51.9%
0.00%
-66.7%
Q4 2021$51,546,000
+719.4%
1,231,094
+751.6%
0.01%
+500.0%
Q3 2021$6,291,000
-60.8%
144,570
-57.4%
0.00%
-50.0%
Q2 2021$16,038,000
-22.3%
339,217
-15.8%
0.00%
-33.3%
Q1 2021$20,643,000
+717.2%
402,641
+326.8%
0.00%
Q4 2020$2,526,000
+80.3%
94,334
+131.2%
0.00%
Q3 2020$1,401,000
+20.2%
40,809
+43.4%
0.00%
Q2 2020$1,166,000
+85.1%
28,459
+54.8%
0.00%
Q1 2020$630,000
+223.1%
18,386
+19.0%
0.00%
Q4 2019$195,00015,4520.00%
Other shareholders
VIR BIOTECHNOLOGY INC shareholders Q4 2020
NameSharesValueWeighting ↓
Bill & Melinda Gates Foundation 1,559,142$14,609,16117.42%
SB INVESTMENT ADVISERS (UK) LTD 16,684,041$156,329,4641.29%
Octagon Capital Advisors LP 325,050$3,045,7190.47%
SECTOR GAMMA AS 148,538$1,391,8010.36%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 1,345,635$12,608,6000.31%
ALGERT GLOBAL LLC 449,685$4,2140.20%
Quantamental Technologies LLC 18,519$173,5230.16%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 47,000$439,9200.15%
DUALITY ADVISERS, LP 123,871$1,160,6710.14%
Empowered Funds, LLC 385,135$3,608,7150.11%
View complete list of VIR BIOTECHNOLOGY INC shareholders